Approval · Notice of Compliance 37310 · 2026
VUEWAY: Notice of Compliance 37310
Issued April 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37310
- Date
- April 10, 2026
- Company
- Bracco Imaging CanadaVille D'Anjou, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VUEWAY | 02567334 | Marketed |
Medicinal ingredients
- GADOPICLENOL 485.1 MG per ML